E-mox Suspension

Composition

Inactive ingredients:

E-MOX Capsules: Maize starch, Microcrystalline cellulose, Talc purified, Magnesium stearate, colloidal silicon dioxide, gelatin, titanium dioxide, brilliant blue, carmosine, ponceau quinoline.

E-MOX Dry Mix: Sucrose, carboxymethylcellulose sodium, caramel oil, banana flavour oil, lactose monohydrate, vanillin, sodium citrate anhydrous, colloidal silicon dioxide, sodium benzoate.

Therapeutic Indications

E-MOX is indicated for the treatment of the following infections in Adults and Children:

Acute otitis media.

Acute bacterial sinusitis.

Acute streptococcal tonsillitis and pharyngitis.

Acute exacerbations of chronic bronchitis.

Community acquired pneumonia.

Acute cystitis.

Asymptomatic bacteriuria in pregnancy.

Acute pyelonephritis.

Typhoid and paratyphoid fevers.

Dental abscess with spreading cellulitis.

Prosthetic joint infections.

Helicobacter pylori  eradication.

Lyme disease.

E-MOX is also indicated for the prophylaxis of endocarditis.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.